FindTrial
Sign In

Molecular classification in community acquired pneumonia based on the omics spectrum

Molecular classification in community acquired pneumonia based on the omics spectrum

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16010218
Enrollment
Unknown
Registered
2016-12-21
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community acquired pneumonia(CAP)

Interventions

Severe CAP group:Collect respiratory specimens and peripheral blood
Mild CAP group: Collect respiratory specimens and peripheral blood
Control group: Collect respiratory specimens and peripheral blood

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged=18 years old; 2. Community acquired pneumonia patients.

Exclusion criteria

Exclusion criteria: 1. Patients with confirmed or highly suspected of HIV infection; 2. Patients with confirmed or highly suspected of tuberculosis infection; 3. Patients with confirmed or highly suspected of non-infectious diseases.

Design outcomes

Primary

MeasureTime frame
Mortality during hospitalization;—

Secondary

MeasureTime frame
Meta-genome of respiratory specimens ;Whole-genome of respiratory pathogens;Host transcriptome;Host methylome;Host serum proteomics;—

Countries

China

Contacts

Public ContactZhancheng Gao

Peking University People's Hospital

gaozhancheng5446@163.com+86 13811957627

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026